Page last updated: 2024-08-21

erythromycin and sparfloxacin

erythromycin has been researched along with sparfloxacin in 33 studies

Research

Studies (33)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	17 (51.52)	18.2507
2000's	13 (39.39)	29.6817
2010's	3 (9.09)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Arakawa, Y; Kato, H; Kimura, K; Konda, T; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K	1
Lombardo, F; Obach, RS; Waters, NJ	1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM	1
Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bebear, C; Renaudin, H	1
Appelbaum, PC; Jacobs, MR; Spangler, SK	1
Cartwright, FD; Kenny, GE	1
Cassell, GH; Crabb, D; Duffy, LB; Pate, MS; Schmid, T; Waites, KB	1
Dorr, MB; Edelstein, MA; Edelstein, PH; Weidenfeld, J	1
Iwamoto, Y; Miyake, Y; Okuda, K; Suginaka, H; Tsuruda, K	1
Appelbaum, PC; Jacobs, MR; Pankuch, GA	1
Gaja, M; Saito, A	1
Garau, J; Grassi, C; Hosie, J; Huchon, G; Legakis, N; Lode, H; Segev, S; Wijnands, G	1
Aubier, M; Gialdroni-Grassi, G; Hosie, J; Huchon, G; Legakis, N; Lode, H; Regamey, C; Segev, S; Tolstuchow, N; Vester, R; Wijnands, WJ	1
Appelbaum, PC; Jacobs, MR; Lichtenberger, C; Pankuch, GA	1
Mandell, GL; Townsend, GC	1
Andrews, JM; Boswell, F; Brenwald, NP; Wise, R	1
Barrett, MS; Jones, RN	1
Dasgupta, MK; Larabie, M; Micetich, RG; Salama, S; Shishido, H; Singh, R	1
Bébéar, C; Bébéar, CM; Leblanc, F; Renaudin, H; Schaeverbeke, T	1
Marre, R; Trautmann, M	1
Goss, TF; Najib, MM; Stein, GE	1
Matsumoto, A; Matsushima, T; Miyashita, N	1
Bebear, C; Bebear, CM; Charron, A; Gruson, D; Lefrancois, M; Renaudin, H	1
Blandino, G; Caccamo, F; Milazzo, I; Musumeci, R; Nicoletti, G; Speciale, A	1
Katouno, Y; Kobayashi, Y; Sugita, K; Uchida, H	1
Harigae, H; Ishikawa, S; Kaku, M; Kanemitsu, K; Kunishima, H; Saga, T; Takemura, H	1
Higashide, M; Kikuchi, K; Ohtsuka, M; Okada, K; Shundo, K; Sunakawa, K	1

Trials

2 trial(s) available for erythromycin and sparfloxacin

Article	Year
Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin. The European respiratory journal, 1995, Volume: 8, Issue:12 Topics: Adolescent; Adult; Aged; Amoxicillin; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Gastrointestinal Diseases; Humans; Male; Middle Aged; Pneumonia, Bacterial; Quinolones; Treatment Failure	1995
Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies. The Journal of antimicrobial chemotherapy, 1996, Volume: 37 Suppl A Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Penicillins; Pneumonia, Bacterial; Quinolones; Streptococcus pneumoniae	1996

Article

Year

Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin.

The European respiratory journal, 1995, Volume: 8, Issue:12

Topics: Adolescent; Adult; Aged; Amoxicillin; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Gastrointestinal Diseases; Humans; Male; Middle Aged; Pneumonia, Bacterial; Quinolones; Treatment Failure

1995

Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies.

The Journal of antimicrobial chemotherapy, 1996, Volume: 37 Suppl A

Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Penicillins; Pneumonia, Bacterial; Quinolones; Streptococcus pneumoniae

1996

Other Studies

31 other study(ies) available for erythromycin and sparfloxacin

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9 Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Malates; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Uncoupling Agents	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship	2008
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
[In vitro activity of sparfloxacin against mycoplasmas]. Pathologie-biologie, 1992, Volume: 40, Issue:5 Topics: Culture Media; Dose-Response Relationship, Drug; Doxycycline; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; In Vitro Techniques; Mycoplasma; Mycoplasma fermentans; Mycoplasma pneumoniae; Ofloxacin; Quinolones; Ureaplasma urealyticum	1992
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:4 Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Quinolones; Streptococcus pneumoniae; Vancomycin; Virginiamycin	1992
Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:3 Topics: Anti-Infective Agents; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Ofloxacin; Quinolones; Tetracycline	1991
In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:6 Topics: Anti-Infective Agents; Ciprofloxacin; Clindamycin; Culture Media; Erythromycin; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma pneumoniae; Tetracycline; Ureaplasma	1991
In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:11 Topics: Animals; Anti-Infective Agents; Antibodies, Bacterial; Body Weight; Ciprofloxacin; Erythromycin; Fluoroquinolones; Guinea Pigs; Half-Life; In Vitro Techniques; Legionella; Legionnaires' Disease; Lung; Macrophages; Male; Microbial Sensitivity Tests; Pulmonary Alveoli	1990
In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria. Journal of periodontal research, 1995, Volume: 30, Issue:4 Topics: Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Anti-Infective Agents; Antitrichomonal Agents; Clindamycin; Erythromycin; Fluoroquinolones; Metronidazole; Microbial Sensitivity Tests; Minocycline; Miocamycin; Naphthyridines; Ofloxacin; Porphyromonas gingivalis; Prevotella intermedia; Quinolones; Tetracycline	1995
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:9 Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Kinetics; Microbial Sensitivity Tests; Penicillin G; Quinolones; Streptococcus pneumoniae; Time Factors; Vancomycin; Virginiamycin	1994
In vitro and in vivo activities of sparfloxacin in Legionella infections. Drugs, 1995, Volume: 49 Suppl 2 Topics: Adult; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Erythromycin; Fluoroquinolones; Guinea Pigs; Humans; In Vitro Techniques; Legionella pneumophila; Legionnaires' Disease; Male; Microbial Sensitivity Tests; Neutrophils; Quinolones; Survival	1995
Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:7 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Penicillins; Quinolones; Streptococcus pneumoniae; Time Factors; Virginiamycin	1996
The new antibiotics, 1997. Virginia medical quarterly : VMQ, 1997,Spring, Volume: 124, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Erythromycin; Fluoroquinolones; Humans; Macrolides; Meropenem; Penicillins; Piperacillin; Quinolones; Thienamycins	1997
The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones. The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteroides fragilis; Chlamydia; Ciprofloxacin; Clarithromycin; Doxycycline; Enterobacter; Erythromycin; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Haemophilus influenzae; Microbial Sensitivity Tests; Naphthyridines; Piperazines; Pseudomonas aeruginosa; Quinolones; Streptococcus pneumoniae	1997
Antimicrobial activity and spectrum of sparfloxacin tested against erythromycin-resistant Streptococcus pneumoniae isolates. Diagnostic microbiology and infectious disease, 1996, Volume: 24, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones; Streptococcus pneumoniae	1996
The effects of macrolide and quinolone antibiotics in methicillin-resistant Staphylococcus aureus biofilm growth. Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 1997, Volume: 13 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Catheterization; Ciprofloxacin; Erythromycin; Fluoroquinolones; Methicillin Resistance; Quinolones; Staphylococcus aureus	1997
In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas. The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:5 Topics: Anti-Infective Agents; Ciprofloxacin; Doxycycline; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Mycoplasma; Ofloxacin; Piperazines; Ureaplasma urealyticum	1999
[Community-acquired respiratory tract infections. Current data on the efficacy of various classes of antibiotics and antibiotic resistance of the main prevalent bacteria species]. Medizinische Klinik (Munich, Germany : 1983), 1999, Nov-15, Volume: 94, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Germany; Haemophilus influenzae; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Population Surveillance; Respiratory Tract Infections; Sampling Studies; Streptococcus pneumoniae; Tetracycline	1999
Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia. Pharmacotherapy, 2000, Volume: 20, Issue:4 Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Azithromycin; Cefaclor; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Erythromycin; Fluoroquinolones; Humans; Models, Economic; Outpatients; Pneumonia; Treatment Outcome	2000
In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains. Microbiology and immunology, 2000, Volume: 44, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Glycogen; Humans; Male; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Plasmids; Urethritis	2000
In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:9 Topics: Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mycoplasma hominis; Naphthyridines; Ofloxacin; Ureaplasma urealyticum	2000
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates. International journal of antimicrobial agents, 2002, Volume: 19, Issue:2 Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma; Quinolines; Streptococcus; Teicoplanin; Thienamycins; Vancomycin	2002
[Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori]. The Japanese journal of antibiotics, 2002, Volume: 55, Issue:6 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Gastric Mucosa; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Penicillins; Stomach Ulcer	2002
Efficacy of amikacin combinations for nocardiosis. The Tohoku journal of experimental medicine, 2003, Volume: 201, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Ciprofloxacin; DNA, Ribosomal; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Male; Middle Aged; Minocycline; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Streptomyces; Sulfamethoxazole; Trimethoprim	2003
[Susceptibility testing and molecular epidemiology of clinical strains of Bordetella pertussis isolated in Japan from 2001 to 2002]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2004, Volume: 78, Issue:5 Topics: Anti-Bacterial Agents; Bordetella pertussis; Child, Preschool; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Female; Fluoroquinolones; Humans; Infant; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Rifampin; Tetracyclines; Whooping Cough	2004